Publications
-
Cortés-Saladelafont E, Molero M, Duarte S, Casado-Rio M, Sierra-March C, O'Callaghan-Gordo M, Sanmarti FX, Fons-Estupina C, González V, Pérez-Dueñas B, Poo P, Ramos F, García-Alix A, Armstrong-Moron J, Artuch-Iriberri R and Garcia-Cazorla A.
Supplementation with pyridoxal phosphate may be useful in diverse neuropediatric disorders.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY . : .
-
Millevert C, Hairabedian M, Dahan S, Lemke J, Syrbe S, Roza E, Teleanu RI, Licchetta L, Cordelli DM, Bisulli F, Hammer TB, Krygier M, Pietruszka M, Mazurkiewicz-Beldzinska M, Mete Dagdas S, Gencpinar P, Fons-Estupina C, Casas-Alba D, Cooper EC, Taglialatela M, Desnous B, Villeneuve N, Lépine A, Auvin S, Mignot C, Ville D, de Saint Martin A, Bar C, Hachon le Camus C, Villard L, Chaton L, Van Bogaert P, Lefranc J, Lesca G, Napuri S, Kuchenbuch M, Perriard C, Dozieres B, Héron B, Ting-Gee Chiu A, Scheffer IE, Milh M and Weckhuysen S.
Early sodium channel blocker initiation is associated with better outcomes in KCNQ2 disorders.
BRAIN . : .
